Royalty PharmaRPRX 
$28.21-0.11%24h
-0.11%24h
Global rank1303
Market cap$12.63B
Change 7d-2.72%
YTD Performance0.79%
SP500 benchmarkUnderperform
P/E11.15
P/S5.36
Revenue$2.35B
Earnings$1.70B
Dividend yield2.8%
Main Sector
Healthcare
Royalty Pharma (RPRX) Net Assets
RPRX Net Assets in 2023: $10.08B
As of 10 Nov 2024, Royalty Pharma net assets is $10.08B, an increase of 5.87% to 2022. Net assets are calculated as total assets minus total liabilities. This value represents the Royalty Pharma overall net worth, providing an insight into company's financial health and stability. Net assets are a key indicator of a stock value, reflecting what it essentially owns minus what it owes.
Royalty Pharma Net Assets History from 2018 to 2024
-
Value:-
RPRX Net Assets History by year
| Year | Net assets | Change |
|---|---|---|
| 2023 | $10.08B | 5.87% |
| 2022 | $9.53B | -7.06% |
| 2021 | $10.25B | 3.56% |
| 2020 | $9.90B | 61.13% |
| 2019 | $6.14B | 36.83% |
| 2018 | $4.49B | - |
View the Top Net Assets Companies
